Sort by
Refine Your Search
-
without a molecular diagnosis. You will also have opportunity to support other natural history and treatment research studies, in addition to your primary research project. There will be the possibility
-
limited to: Assess therapeutic response in primary CRC organoids in vitro and implanted tumours in vivo Loss-of-functional whole-genome/sub-genome CRISPR screen in vitro and in vivo to reveal treatment
-
and research infrastructure makes UCL a global leader. Dr Nnenna Kanu is the Chief Scientific Officer of the Cancer Research UK Lung Cancer centre of Excellence. The Kanu Lab is a multi-disciplinary
-
molecular cloning and animal models is essential. The post holder will join a team of scientists at ICH as well as linking with the collaborating groups at the partner Institutions in the collaboration. Main
-
cortical atrophy (PCA), primary progressive aphasia (PPA), behavioural variant frontotemporal dementia (bvFTD), and people living at-risk of inheriting frontotemporal dementia (fFTD) or Alzheimer’s disease
-
postdoctoral fellow roles, suitable for early career researchers who are at the point of completing their PhD or who have recently completed their PhD. The appointed Fellows will work with the project Principal
-
About us UCL School of Pharmacy is one of the world’s leading centres of excellence for pharmaceutical science, education and professional engagement. The Division has a well-established track
-
improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics
-
improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics
-
Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. About Queen Mary At Queen Mary University of London, we believe that a diversity